glp 1 for metabolic syndrome The multifaceted role of GLP-1 in disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential GLP-1 Agonists For Obesity In

Paromomycin (PM), an aminoglycoside antibiotic, is an affordable and effective option for treating leishmaniasis, administered intramuscularly at 15 mg/kg/day for 21 days

[Dabigatran: a new therapeutic alternative in the prevention of stroke]

It can even cause anovulatory cycles and amenorrhea, or a loss of a period

Curated research selection for tissue and regenerative research models

In vivo photopharmacology

Pharmaceutical Executive spoke with Susan Thomas, chief commercial officer at LucyRx, about the companys efforts to provide coverage models for GLP-1s and why its so important to provide these medications for general health purposes